Equifax Stock Climbs As Street Trims Targets But Backs Strategy

Equifax Inc. stocks have been trading up by 11.24 percent amid strong positive sentiment from impactful credit-data innovation news.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading EFX

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Wall Street banks have cut Equifax (EFX) price targets, but most still rate the stock Buy or Overweight with average targets around the mid‑$190s to roughly $210.
BofA Securities trimmed Q3 2026 estimates on weaker mortgage revenue as 30‑year mortgage rates above 7% weigh on loan volumes, yet kept a Buy rating into the 2026/10/20 earnings.
RBC and others flag macro headwinds and FHFA regulatory risk, including a possible bi‑merge credit reporting model that could alter the competitive landscape.
Rapid adoption of VantageScore 4.0, FHFA approval, and a $1 pricing strategy extended through 2028 highlight Equifax’s push to grab share in mortgage scoring.
New launches like Mortgage Score Select, Mortgage Ultimate, and an expanded Mastercard Open Finance deal show EFX leaning into automation, open banking, and multi‑score mortgage workflows.

Live Update At 15:02:47 EDT: On Tuesday, October 20, 2026 Equifax Inc. stock [NYSE: EFX] is trending up by 11.24%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

EFX has been in a strong upswing on the chart. From 2026/09/30 to 2026/10/20, Equifax stock bounced from about $137 to a close near $176.38, a roughly 29% move in three weeks. That is a serious trend for active trading.

The intraday tape on the latest session shows EFX opening at $166.11 and grinding higher all day, with buyers in control into the close. Price pushed as high as $177.80 and finished near the top of the range. That is classic momentum action — shallow pullbacks, steady higher lows, and strength into the bell.

Under the hood, Equifax is not some story with no earnings. Revenue over the last year sits around $6.07B, with gross margin near 79.6% and EBIT margin about 18%. The latest quarterly report (period ended 2026/06/30) showed $1.70B in revenue, $314.2M in operating income, and about $183.9M in net income. EFX generated $339.8M in operating cash flow and $204.8M in free cash flow that quarter.

More Breaking News

Valuation is not dirt cheap. The P/E near 25.6 and price‑to‑sales around 2.66 tell traders they are paying up for a quality, data‑driven franchise. But the steady returns on equity in the mid‑teens and solid cash generation keep longer‑term bulls engaged.

Why Traders Are Watching EFX Into Earnings

EFX is heading into its Q3 2026 report on 2026/10/20 with a rare mix of technical strength and headline noise. On one side, nearly every major broker has walked targets lower. On the other, Equifax keeps rolling out products that try to reshape mortgage and data workflows.

Bank of America cut its Equifax price target from $210 to $200 and modestly trimmed Q3 estimates, pointing straight at high mortgage rates over 7% choking loan demand. RBC Capital slashed its target from $194 to $177, citing softer consumer lending and the risk that the FHFA moves to a bi‑merge credit reporting model. Mizuho dropped its target to $185 from $210. Deutsche Bank, Jefferies, Morgan Stanley, and Rothschild & Co Redburn all joined the target‑cut club.

Yet the tone across this research is not “EFX is broken.” It is “near‑term headwinds, longer‑term franchise.” Most of these firms still rate Equifax Buy, Outperform, or Overweight, with mean Street targets hovering in the mid‑$190s to around $210 — still well above where EFX currently trades.

At the same time, Equifax is not standing still. EFX is reporting rapid adoption of its VantageScore 4.0 model in the mortgage industry, helped by FHFA approval for Fannie Mae and Freddie Mac loans and a $1 pricing strategy extended through 2028. That is an aggressive land‑grab: sacrifice price now, win volume and entrenchment later.

The company also launched Mortgage Score Select, letting lenders flex between VantageScore 4.0, Classic FICO, and later FICO 10T, or even pull files without scores and repull within 24 hours for $1. Add Mortgage Ultimate — a largely automated income and employment verification platform slated for early 2027 — and an expanded Mastercard Open Finance partnership for open banking and cash‑flow analytics, and it is clear EFX is betting big on automation and alternative data.

For traders, this all sets up a classic catalyst: a strong chart, lowered expectations, and a company talking long‑game product strategy.

Conclusion

Into the 2026/10/20 earnings call, EFX sits at the center of a tug‑of‑war. Bears point to the obvious: 30‑year mortgage rates above 7%, softer consumer lending, and FHFA regulatory overhang. That is why Bank of America, RBC, Mizuho, Deutsche Bank, Morgan Stanley, Jefferies, and others have taken the red pen to their Equifax price targets.

Bulls counter with the tape and the roadmap. The recent surge in Equifax stock from the $130s to the mid‑$170s shows traders are willing to pay for a high‑margin data business that still throws off strong cash. The Street’s average target in the mid‑$190s to roughly $210 says many expect more upside if execution holds.

What stands out most is how aggressively EFX is leaning into the next mortgage cycle. VantageScore 4.0 at $1, Mortgage Score Select, Mortgage Ultimate, and the Mastercard Open Finance expansion all aim to lock lenders into Equifax data pipes before the multi‑score regime fully hits around 2027. If that works, mortgage headwinds today can translate into leverage tomorrow.

For active traders, the plan is simple: watch how management talks about mortgage volumes, FHFA risk, and product uptake on the Q3 call — then let the price action confirm or reject the story. As Tim Sykes loves to say, “The market doesn’t care about your opinion, only your preparation — study the catalyst, study the chart, and be ready to cut losses fast.” And as a complementary reminder about trading mindset, As Tim Bohen, lead trainer with StocksToTrade says, “Time and experience have taught me that missed opportunities are part of the game. There’s always another setup around the corner.” This coverage is for educational and research purposes only, but the EFX setup is one every serious trader should be studying right now.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!